Although Vγ9Vδ2 T cells derived from human PBMCs demonstrated good cytotoxicity against gliomas that overexpress BTN2A1/BTN3A1, such overexpression occurred in less than 30% of GBM cases. The gene discussed is BTN2A1; the disease is glioblastoma.